Commission Implementing Regulation (EU) 2024/821of 8 March 2024renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011(Text with EEA relevance)

32024R0821

European Union